45 studies found for:    "Pars planitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pars planitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis;   Noninfectious Uveitis
Intervention: Drug: triamcinolone acetonide (Triesence®)
2 Not yet recruiting Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Conditions: Uveitis;   Anterior Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Scleritis;   Clinically Significant Macular Edema
Intervention: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
3 Recruiting A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Intervention: Drug: FAI insert
4 Recruiting Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: Sham Injection;   Drug: FAI Insert
5 Active, not recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
6 Unknown  Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Interventions: Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
7 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
8 Completed Retisert and Cataract Surgery in Patients With Severe Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Intervention: Device: Retisert (fluocinolone acetonide implant)
9 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Interventions: Drug: Dexamethasone;   Drug: dexamethasone;   Drug: Sham injection
10 Recruiting Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
Conditions: Non-infectious Intermediate Uveitis;   Non-infectious Posterior Uveitis;   Non-infectious Panuveitis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
11 Completed Quality of Life in Patients With Intermediate Uveitis
Condition: Macular Edema
Intervention:
12 Active, not recruiting Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Uveitis, Intermediate
Interventions: Drug: Myfortic;   Drug: Decortin
13 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
14 Recruiting Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
Conditions: Uveitis;   Uveitis, Posterior;   Uveitis, Anterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: 4mg CLS-TA Suprachoriodal Injection;   Drug: Sham Procedure
15 Completed Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
16 Not yet recruiting Safety &Efficacy of CF101 to Subjects With Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Interventions: Drug: CF101;   Drug: Placebo
17 Terminated Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Intervention: Drug: V404
18 Recruiting Study of the Effectiveness of Ozurdex for the Control of Uveitis
Conditions: Uveitis, Intermediate;   Uveitis, Posterior
Intervention: Drug: Dexamethasone pellet
19 Completed A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
20 Completed A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years